GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » T&R Biofab Co Ltd (XKRX:246710) » Definitions » Debt-to-Revenue

T&R Biofab Co (XKRX:246710) Debt-to-Revenue : 8.95 (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is T&R Biofab Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

T&R Biofab Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩22,864 Mil. T&R Biofab Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩16,398 Mil. T&R Biofab Co's annualized Revenue for the quarter that ended in Sep. 2024 was ₩4,386 Mil. T&R Biofab Co's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 8.95.


T&R Biofab Co Debt-to-Revenue Historical Data

The historical data trend for T&R Biofab Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T&R Biofab Co Debt-to-Revenue Chart

T&R Biofab Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.87 0.14 4.70 3.66 8.85

T&R Biofab Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.90 8.01 7.81 6.78 8.95

Competitive Comparison of T&R Biofab Co's Debt-to-Revenue

For the Medical Devices subindustry, T&R Biofab Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


T&R Biofab Co's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, T&R Biofab Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where T&R Biofab Co's Debt-to-Revenue falls into.



T&R Biofab Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

T&R Biofab Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(29317.995 + 16703.385) / 5199.194
=8.85

T&R Biofab Co's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(22864.323 + 16397.999) / 4386.48
=8.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


T&R Biofab Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of T&R Biofab Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


T&R Biofab Co Business Description

Traded in Other Exchanges
N/A
Address
Sangidaehak-ro 237, Gyeonggi-do, Siheung-si, KOR, 540
T&R Biofab Co Ltd is a Korea based biomedical engineering company. It is mainly engaged in manufacturing bioresorbable scaffolds that aids in regeneration and reconstruction of tissues and organs using innovative 3D printing technology.

T&R Biofab Co Headlines

No Headlines